Covington Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Covington Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$49K	Hold	618	–	–	﹤0.01%	573
2022 Q2	$46K	Hold	618	–	–	﹤0.01%	581
2022 Q1	$56K	Hold	618	–	–	﹤0.01%	562
2021 Q4	$69K	Hold	618	–	–	﹤0.01%	501
2021 Q3	$78K	Hold	618	–	–	﹤0.01%	482
2021 Q2	$84K	Hold	618	–	–	﹤0.01%	469
2021 Q1	$84K	Hold	618	–	–	﹤0.01%	428
2020 Q4	$87K	Hold	618	–	–	﹤0.01%	407
2020 Q3	$69K	Hold	618	–	–	﹤0.01%	418
2020 Q2	$69K	Buy	618 +32	+5%	+$3.15K	﹤0.01%	407
2020 Q1	$45K	Buy	586 +8	+1%	+$708	﹤0.01%	433
2019 Q4	$55K	Hold	578	–	–	﹤0.01%	459
2019 Q3	$44K	Hold	578	–	–	﹤0.01%	458
2019 Q2	$51K	Hold	578	–	–	﹤0.01%	441
2019 Q1	$52K	Hold	578	–	–	﹤0.01%	419
2018 Q4	$41K	Buy	+578	New	+$46.6K	﹤0.01%	453

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Covington Capital Management's XBI Position: Q3 2022 in Review

Covington Capital Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2022 at 618 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #573.

Covington Capital Management first reported a position in XBI in Q4 2018 and has held it in 16 quarters since. The position peaked at $87K in Q4 2020. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Covington Capital Management held 618 shares of State Street SPDR S&P Biotech ETF worth $49K as of Q3 2022.
Covington Capital Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2022.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #573 holding.
Covington Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 16 quarters since.
Covington Capital Management's State Street SPDR S&P Biotech ETF position peaked at $87K in Q4 2020.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.